Ya-Tao Wang

Targeting 4-1BB for tumor immunotherapy from bench to bedside

Hong Jiao, Qi-Bing Liu, W. Ji, 2022, Frontiers in Immunology.

The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application

Jin-ling Huo, N. Lu, Ya-Tao Wang, 2022, Frontiers in Immunology.

Down-expression of the NLRP3 inflammasome delays the progression of diabetic retinopathy.

Zongming Song, Handong Dan, Ya-Tao Wang, 2021, Microvascular research.